Pacific Sage Partners’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,793
Closed -$216K 130
2026
Q1
$216K Buy
+1,793
New +$207K 0.03% 115
2024
Q4
Sell
-1,927
Closed -$219K 108
2024
Q3
$219K Sell
1,927
-47
-2% -$5.58K 0.05% 91
2024
Q2
$244K Buy
1,974
+38
+2% +$4.89K 0.06% 82
2024
Q1
$255K Sell
1,936
-68
-3% -$8.38K 0.07% 81
2023
Q4
$218K Buy
+2,004
New +$208K 0.06% 81
2023
Q3
Sell
-1,962
Closed -$226K 89
2023
Q2
$226K Buy
1,962
+1
+0.1% +$114 0.07% 75
2023
Q1
$209K Sell
1,961
-269
-12% -$29K 0.07% 79
2022
Q4
$247K Buy
+2,230
New +$228K 0.08% 70

Other funds holding MRK

Pacific Sage Partners's MRK Position: Q2 2026 in Review

Pacific Sage Partners sold out of Merck (MRK) in Q2 2026, closing a stake of 1,793 shares — an estimated $216K sold.

Pacific Sage Partners first reported a position in MRK in Q4 2022 and held it in 8 quarters. The position peaked at $255K in Q1 2024. 3,818 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Pacific Sage Partners reported no remaining Merck position as of Q2 2026 after selling out during the quarter.
  • Pacific Sage Partners sold 1,793 Merck shares in Q2 2026, an estimated $216K.
  • Pacific Sage Partners first reported a position in Merck in Q4 2022 and held it in 8 quarters.
  • Pacific Sage Partners's Merck position peaked at $255K in Q1 2024.
  • 3,818 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Pacific Sage Partners's 13F filing for Q2 2026, filed 6 Aug 2026.